2026-01 Managers and closely related parties transactions with Demant shares.pdf
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
13.1.2026 13:14:33 CET | Demant A/S | Managers' Transactions
Company announcement no 2026-01 | 13 January 2026 |
Transactions with Demant shares by managers and closely related parties
Notification pursuant to article 19 of the Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | Søren Nielsen |
2. | Reason for the notification | |
a) | Position/status | President & CEO |
b) | Initial notification/amendment | Initial notification |
3) | Details of the issuer, emission allowance market participant, auction platform, | |
a) | Name | Demant A/S |
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase of shares under share salary arrangement in |
c) | Price(s) and volume(s) | Price(s) Volume(s)
Allocated shares from January until December 2025:
DKK 270.50 per share 200 shares DKK 256.50 per share 211 shares DKK 220.34 per share 246 shares DKK 242.06 per share 230 shares DKK 277.90 per share 200 shares DKK 265.67 per share 210 shares DKK 254.37 per share 219 shares DKK 249.07 per share 224 shares DKK 231.98 per share 240 shares DKK 222.23 per share 251 shares DKK 214.53 per share 260 shares DKK 218.19 per share 255 shares
The share price corresponds to the prices of the allocated shares during the 8th day after the end of the respective month or on the next trading day hereafter. |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 2,746 shares Aggregated price: DKK 663,839.53 |
e) | Date of the transaction | 8 January 2026 |
f) | Place of the transaction | Nasdaq Copenhagen A/S |
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | Niels Wagner |
2. | Reason for the notification | |
a) | Position/status | President of Hearing Care |
b) | Initial notification/amendment | Initial notification |
3) | Details of the issuer, emission allowance market participant, auction platform, | |
a) | Name | Demant A/S |
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase of shares under share salary arrangement in |
c) | Price(s) and volume(s) | Price(s) Volume(s)
Allocated shares from January until December 2025:
DKK 270.50 per share 239 shares DKK 256.50 per share 252 shares DKK 220.34 per share 294 shares DKK 242.06 per share 275 shares DKK 277.90 per share 240 shares DKK 265.67 per share 251 shares DKK 254.37 per share 262 shares DKK 249.07 per share 267 shares DKK 231.98 per share 288 shares DKK 222.23 per share 300 shares DKK 214.53 per share 311 shares DKK 218.19 per share 305 shares
The share price corresponds to the prices of the allocated shares during the 8th day after the end of the respective month or on the next trading day hereafter. |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 3,284 shares Aggregated price: DKK 793,905.78 |
e) | Date of the transaction | 8 January 2026 |
f) | Place of the transaction | Nasdaq Copenhagen A/S |
Further information: Peter Pudselykke, Head of Investor Relations Henrik Axel Lynge Buchter, Communication Manager
Phone +45 3917 7300 |
Contacts
- Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 22,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.